Overview

Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction

Status:
NOT_YET_RECRUITING
Trial end date:
2029-05-31
Target enrollment:
Participant gender:
Summary
This study aimed to evaluate the efficacy and safety of bronchoscopic cryoablation combined with sintilimab plus platinum-based chemotherapy as First-line Treatment for locally advanced or metastatic NSCLC with central airway obstruction.
Phase:
PHASE2
Details
Lead Sponsor:
Hunan Province Tumor Hospital
Treatments:
130-nm albumin-bound paclitaxel
Carboplatin
sintilimab